10-K/A XBRL

FORM 10-K/A AMENDED ANNUAL REPORT

Company: AXIM BIOTECHNOLOGIES, INC.
Filed: April 26, 2021
Period of Report: December 31, 2020
Accession Number: 0001078782-21-000395

View Document ↗ View on SEC.gov ↗